The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
Open accessAbstract
Mortality from coronavirus disease 2019 (COVID-19) in populations at high risk, such as the elderly, certain ethnic groups (e.g., Black/African American, and Hispanic/Latino persons), obese individuals, and those with endothelial dysfunction is substantial. While treatment options are limited, vaccination against SARS-CoV-2, the virus that causes COVID-19, is the most important global strategy in controlling the pandemic. Thus, two lipid nanoparticle (LNP)-based mRNA vaccines (Pfizer-BioNTech and Moderna) against SARS-CoV-2 have already received emergency use authorization by the US Food and Drug Administration (FDA).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retraction for Pushparaj et al., The cytokine interleukin-33 mediates anaphylactic shock
(2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210844109 · Cited by 4
RetractedThe pathophysiology of anaphylaxis
Reber, L. L., Hernandez, J. D., & Galli, S. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.003 · Cited by 534
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e1 · Cited by 481
Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383
Risk of anaphylaxis after vaccination in children and adults.
McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., Hambidge, S. J., Lee, G. M., Jackson, L. A., Irving, S. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.048 · Cited by 381
Pathways of anaphylaxis in the mouse.
Strait, R., Morris, S., Yang, M.-Y., Qu, X.-W., & Finkelman, F. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123302 · Cited by 326
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 275
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270
Wibroe, P. P., Ahmadvand, D., Oghabian, M. A., Yaghmur, A., & Moghimi, S. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.021 · Cited by 203
Polyvinyl Pyrrolidone as a Plasma Expander
Ravin, H. A., Seligman, A. M., & Fine, J. (1952) · New England Journal of Medicine · doi:10.1056/nejm195212112472403 · Cited by 196
Cited by
Sorted by citations
The dawn of mRNA vaccines: the COVID-19 case
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504
COVID-19 vaccine development: milestones, lessons and prospects
Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 478
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Trougakos, I. P., Terpos, E., Alexopoulos, H., Politou, M., Paraskevis, D., Scorilas, A., Kastritis, E., Andreakos, E., & Dimopoulos, M. A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.007 · Cited by 273
Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy
You, Y., Tian, Y., Yang, Z., Shi, J., Kwak, K. J., Tong, Y., Estania, A. P., Cao, J., Hsu, W.-H., Liu, Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00989-w · Cited by 258
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Kounis, N. G., Koniari, I. C., GREGORIO, C. D., Velissaris, D., Petalas, K., Brinia, A., Assimakopoulos, S. F., Gogos, C., Kouni, S. N., Kounis, G. N., et al. (2021) · Vaccines · doi:10.3390/vaccines9030221 · Cited by 192
Szebeni, J., Storm, G., Ljubimova, J. Y., Castells, M., Phillips, E. J., Turjeman, K., Barenholz, Y., Crommelin, D. J. A., & Dobrovolskaia, M. A. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01071-x · Cited by 170
Padín-González, E., Lancaster, P., Bottini, M., Gasco, P., Tran, L., Fadeel, B., Wilkins, T., & Monopoli, M. P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.882363 · Cited by 166
Scholkmann, F., & May, C.-A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154497 · Cited by 177
Two centuries of vaccination: historical and conceptual approach and future perspectives
Montero, D. A., Vidal, R. M., Velasco, J., Carreño, L. J., Torres, J. P., O., M. A. B., Tovar-Rosero, Y.-Y., Oñate, A. A., & O’Ryan, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1326154 · Cited by 171
Zhang, H., Vandesompele, J., Braeckmans, K., Smedt, S. C. D., & Remaut, K. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00194f · Cited by 146
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
Leong, E. W. X., & Ge, R. (2022) · Biomedicines · doi:10.3390/biomedicines10092179 · Cited by 134
Pro-inflammatory concerns with lipid nanoparticles
Moghimi, S. M., & Simberg, D. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.011 · Cited by 124
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
Leong, K. Y., Tham, S. K., & Poh, C. L. (2025) · Virology Journal · doi:10.1186/s12985-025-02645-6 · Cited by 139
Tang, C., Jing, W., Han, K. S., Yang, Z., Zhang, S., Liu, M., Zhang, J., Zhao, X., Liu, Y., Shi, C., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10109 · Cited by 101
Khalid, K., & Poh, C. L. (2023) · Vaccines · doi:10.3390/vaccines11071264 · Cited by 106
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
Xu, Y., Golubovic, A., Xu, S., Pan, A., & Li, B. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00649b · Cited by 87
Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake
Deuker, M., Mailänder, V., Morsbach, S., & Landfester, K. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00198a · Cited by 78
Beyond Lipids: Exploring Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era
Jogdeo, C. M., Siddhanta, K., Das, A., Ding, L., Panja, S., Kumari, N., & Oupický, D. (2024) · Advanced Materials · doi:10.1002/adma.202404608 · Cited by 76
Dézsi, L., Mészáros, T., Kozma, G. T., H-Velkei, M., Oláh, C. Z., Szabó, M., Patkó, Z., Fülöp, T., Hennies, M., Szebeni, M., et al. (2022) · GeroScience · doi:10.1007/s11357-021-00495-y · Cited by 58
Huang, C., Duan, X., Wang, J., Tian, Q., Ren, Y., Chen, K., Zhang, Z., Li, Y., Feng, Y., Zhong, K., et al. (2022) · Advanced Science · doi:10.1002/advs.202205532 · Cited by 56
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
Bahrani, S. A., Albarrak, A. M., Alghamdi, O. A., Alghamdi, M. A., Hakami, F. H., Abaadi, A. K. A., Alkhrashi, S. A., Alghamdi, M. Y., Almershad, M. M., Alanazi, M. M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.07.052 · Cited by 52
mRNA vaccines in the prevention and treatment of diseases
Gu, Y., Duan, J., Yang, N., Yang, Y., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.167 · Cited by 54
Tsilingiris, D., Vallianou, N. G., Karampela, Ι., Liu, J., & Dalamaga, Μ. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100159 · Cited by 51
Xu, K., Dai, L., & Gao, G. F. (2021) · International Immunology · doi:10.1093/intimm/dxab061 · Cited by 48
From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines
Lopez-Cantu, D. O., Wang, X., Carrasco-Magallanes, H., Afewerki, S., Zhang, X., Bonventre, J. V., & Ruiz‐Esparza, G. U. (2022) · Nano-Micro Letters · doi:10.1007/s40820-021-00771-8 · Cited by 49
Mouliou, D. S., & Dardiotis, E. (2022) · Diagnostics · doi:10.3390/diagnostics12071555 · Cited by 49
Münter, R., Christensen, E., Andresen, T. L., & Larsen, J. B. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.05.008 · Cited by 51
Polyplex designs for improving the stability and safety of RNA therapeutics
Uchida, S., Lau, C. Y. J., Oba, M., & Miyata, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114972 · Cited by 46
Wu, L., Ficker, M., Christensen, J. B., Simberg, D., Trohopoulos, P. N., & Moghimi, S. M. (2021) · Nature Communications · doi:10.1038/s41467-021-24960-6 · Cited by 46
Moghimi, S. M., Haroon, H., Yaghmur, A., Hunter, A. C., Papini, E., Farhangrazi, Z. S., Simberg, D., & Trohopoulos, P. N. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.022 · Cited by 47
Immune Response to SARS-CoV-2 Vaccines
Bellamkonda, N., Lambe, U. P., Sawant, S. A., Nandi, S. S., Chakraborty, C., & Shukla, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071464 · Cited by 37
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19
Sharma, A., Kontodimas, K., & Bosmann, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.648005 · Cited by 39
RETRACTED: Why are we vaccinating children against COVID-19?
Kostoff, R. N., Călina, D. C., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P. G., Svistunov, A. А., & Tsatsakis, A. M. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.08.010 · Cited by 39
RetractedCOVID-19: vaccines, efficacy and effects on variants
Rudan, I., Adeloye, D., & Sheikh, A. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000868 · Cited by 34
Parvin, N., Mandal, T. K., & Joo, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111366 · Cited by 36
Xu, Y., Zheng, Y., Ding, X., Wang, C., Hua, B., Hong, S., Huang, X., Lin, J., Zhang, P., & Chen, W. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2219870 · Cited by 31
Cheng, M., Yu, X., Qi, S., Yang, K., Lu, M., Cao, F., & Yu, G. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202407398 · Cited by 33
Călina, D. C., Hernández, A. F., Härtung, T., Egorov, A. M., Izotov, B. N., Νikolouzakis, Τ. Κ., Tsatsakis, A. M., Vlachoyiannopoulos, P. G., & Docea, A. O. (2021) · Life · doi:10.3390/life11090907 · Cited by 31
Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities
Wang, H., Lin, S., Wu, X., Jiang, K., Lu, H., & Zhan, C. (2023) · Advanced Science · doi:10.1002/advs.202301777 · Cited by 28
Ionizable drug delivery systems for efficient and selective gene therapy
Zhang, Y., Guo, R., Chen, Y., Li, T., Du, W.-Z., Xiang, R., Guan, J., Li, Y., Huang, Y., Yu, Z., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00445-z · Cited by 27
Nanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics
Wu, Q., Yao, X., Duan, X., Chen, X. S., & Zhang, J. (2025) · Advanced Materials · doi:10.1002/adma.202510293 · Cited by 29
Adverse Events following Immunization with COVID‐19 Vaccines: A Narrative Review
Bhandari, B., Rayamajhi, G., Lamichhane, P., & Shenoy, A. K. (2022) · BioMed Research International · doi:10.1155/2022/2911333 · Cited by 28
COVID-19 Vaccines: Current Conditions and Future Prospects
Zieneldien, T., Kim, J., Cao, J. A., & Cao, C. (2021) · Biology · doi:10.3390/biology10100960 · Cited by 24
Safety surveillance and challenges in accelerated COVID-19 vaccine development
Cole, A., Webster, P. S., Liew, D. V., Salas, M., Aimer, O., & Malikova, M. A. (2022) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986221116452 · Cited by 25
Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells
Moraes-Lacerda, T., & de Jesus, M. B. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112863 · Cited by 23
Chang, T.-C., Chen, B., Wu, J.-Y., Cheng, T., & Roffler, S. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112502 · Cited by 26
Zhang, K., Wang, M., Liu, T., Chu, Z., & Jin, W. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c09446 · Cited by 21
Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021) · Cureus · doi:10.7759/cureus.18985 · Cited by 20
Holmes, G. A., Desai, M., Limone, B. A., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021) · JAAD Case Reports · doi:10.1016/j.jdcr.2021.07.038 · Cited by 20
Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles
Fernandes, S., Cassani, M., Cavalieri, F., Forte, G., & Caruso, F. (2023) · Advanced Science · doi:10.1002/advs.202305769 · Cited by 20
van den Ouweland, F., Charpentier, N., Türeci, Ö., Rizzi, R., Mensa, F., Lindemann, C., & Pather, S. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2315659 · Cited by 20
Awaya, T., Hara, H., & Moroi, M. (2024) · Diseases · doi:10.3390/diseases12100231 · Cited by 19
Shin, H., Kang, S., Won, C., & Min, D. (2024) · Advanced Science · doi:10.1002/advs.202404590 · Cited by 18
Haq, H. N., Khan, H., Chaudhry, H., Nimmala, S., Demidovich, J., Papudesi, B. N., & Potluri, S. D. (2022) · Journal of the National Medical Association · doi:10.1016/j.jnma.2022.08.003 · Cited by 17
Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles
Moghimi, S. M., Haroon, H., Yaghmur, A., Simberg, D., & Trohopoulos, P. N. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.039 · Cited by 16
Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
Huang, K., Li, N., Li, Y., Zhu, J., Fan, Q., Yang, J., Gao, Y., Liu, Y., Gao, S., Zhao, P., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c20770 · Cited by 32
Toledo‐Salinas, C., Scheffler‐Mendoza, S., Castaño‐Jaramillo, L. M., Ortega‐Martell, J. A., Del-Rio-Navarro, B. E., Santibáñez-Copado, A. M., Díaz‐Ortega, J. L., Baptista-Rosas, R. C., Sánchez-Novoa, P., Garcia-Grimshaw, M. A., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01350-1 · Cited by 16
Immune-mediated liver injury following COVID-19 vaccination
Schinas, G., Polyzou, E., Dimakopoulou, V., Tsoupra, S., Gogos, C. A., & Akinosoglou, K. (2023) · World Journal of Virology · doi:10.5501/wjv.v12.i2.100 · Cited by 17
Nano-Carriers of COVID-19 Vaccines: The Main Pillars of Efficacy
Constantin, C., Pisani, A., Bardi, G., & Neagu, M. T. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0250 · Cited by 15
Segalla, G. (2023) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/ijvtpr.v3i1.68 · Cited by 15
Glycolipids Substitute PEG lipids in Lipid Nanoparticles for mRNA Delivery
Jin, J., Liang, Z., Wang, Z., Liu, X., Liu, X., An, F., Jiang, T., Gao, X., Wang, X., Liu, C., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16448 · Cited by 14
Xue, W., Li, T., Gu, Y., Li, S., & Xia, N. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2227699 · Cited by 19
Mahdiabadi, S., & Rezaei, N. (2022) · Health Science Reports · doi:10.1002/hsr2.787 · Cited by 15
Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis
Hasan, M., Khatun, A., & Kogure, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122678 · Cited by 14
SARS-CoV-2 spike protein S1 activates Cx43 hemichannels and disturbs intracellular Ca2+ dynamics
Prieto‐Villalobos, J., Lucero, C. M. J., Rovegno, M., Gómez, G. I., Retamal, M. A., & Orellana, J. A. (2023) · Biological Research · doi:10.1186/s40659-023-00468-9 · Cited by 13
A PEG-lipid-free COVID-19 mRNA vaccine triggers robust immune responses in mice
Li, M., Huang, Y., Wu, J., Li, S., Mei, M., Chen, H., Wang, N., Wu, W., Zhou, B., Tan, X., et al. (2022) · Materials Horizons · doi:10.1039/d2mh01260j · Cited by 13
Sivasankar, C., Hewawaduge, C., & Lee, J. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.015 · Cited by 15
Zetrini, A. E., Abbasi, A. Z., He, C., Lip, H., Alradwan, I., Rauth, A. M., Henderson, J. T., & Wu, X. Y. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101206 · Cited by 12
Cari, L., Alhosseini, M. N., Mencacci, A., Migliorati, G., & Nocentini, G. (2023) · Vaccines · doi:10.3390/vaccines11040879 · Cited by 12
Anti-Poly(ethylene glycol) (PEG) Antibodies: From Where Are We Coming and Where Are We Going
Simberg, D., & Moghimi, S. M. (2024) · Journal of Nanotheranostics · doi:10.3390/jnt5030007 · Cited by 11
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
Ramirez, G. A., Asperti, C., Cucca, V., & Yacoub, M. (2021) · Vaccines · doi:10.3390/vaccines9101147 · Cited by 11
Münter, R., Sørensen, E., Hasselbalch, R. B., Christensen, E., Nielsen, S. D., Garred, P., Ostrowski, S. R., Bundgaard, H., Iversen, K. K., Andresen, T. L., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01036 · Cited by 11
du Preez, H. N., Lin, J., Maguire, G. E. M., Aldous, C. M., & Kruger, H. G. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14296 · Cited by 12
Schilz, J., Binder, U., Friedrich, L., Gebauer, M., Lutz, C., Schlapschy, M., Schiefner, A., & Skerra, A. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167113 · Cited by 10
de Melo, B. P., da Silva, J. A. M., Rodrigues, M. A., Palmeira, J. D. F., Saldanha‐Araújo, F., Argañaraz, G. A., & Argañaraz, E. R. (2025) · Viruses · doi:10.3390/v17050617 · Cited by 10
Interpolyelectrolyte Complexes as an Emerging Technology for Pharmaceutical Delivery of Polypeptides
Fay, J. M., & Kabanov, A. V. (2022) · Reviews and Advances in Chemistry · doi:10.1134/s2634827622600177 · Cited by 10
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine
Yacoub, M., Cucca, V., Asperti, C., Ramirez, G. A., Della‐Torre, E., Moro, M., Zandalasini, C., Napoli, D. D., Ambrosio, A. G., Signorelli, C., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.09.048 · Cited by 9
Shah, S. R., Madhu, H., Soniwala, M. M., Mori, D., Vyas, A. J., Chauhan, A., & Prajapati, B. G. (2024) · doi:10.1002/9781394175482.ch7 · Cited by 9
Marx, V., Mochida, Y., Osawa, S., Tockary, T. A., Norimatsu, J., Yokoo, H., Oba, M., & Uchida, S. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c00636 · Cited by 8
Concerns and challenges in clinics-guided nanovaccines design and applications
Gao, Y., Hua, S., Dong, X., Zhang, K., Zhang, X., & Yang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.041 · Cited by 8
Fuchs, E., Rudnik‐Jansen, I., Dinesen, A., Selnihhin, D., Mandrup, O. A., Thiam, K., Kjems, J., Pedersen, F. S., & Howard, K. A. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.048 · Cited by 9
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Pignatti, P., Ramirez, G. A., Russo, M., Marraccini, P., Nannipieri, S., Asperti, C., Torre, F. D., Tiri, A., Gatti, B. M., Gurrado, A., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.06.039 · Cited by 7
Kounis, N. G., Stefanidis, A. S., Hung, M., Özkan, U., GREGORIO, C. D., Ceasovschih, A., Mplani, V., Gogos, C., Assimakopoulos, S. F., Chatzigrigoriadis, C., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12090325 · Cited by 7
Chakraborty, C., Lo, Y.-H., Bhattacharya, M., Das, A., & Wen, Z. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102527 · Cited by 8
Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman
Fujita, M., Ureshino, H., Sugihara, A., Nishioka, A., & Kimura, S. H. (2021) · Cureus · doi:10.7759/cureus.17942 · Cited by 6
Lisiecka, M. Z. (2024) · Immunologic Research · doi:10.1007/s12026-024-09473-w · Cited by 5
Respiratory mucosal vaccines: Applications, delivery strategies and design considerations
Shi, T., Ye, Y., Fan, Z., Yang, Q., Ma, Y., & Zhu, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118326 · Cited by 8
Friedrich, L., Kikuchi, Y., Matsuda, Y., Binder, U., & Skerra, A. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01948-5 · Cited by 5
Future prospects in mRNA vaccine development
Mbatha, L. S., Akinyelu, J., Maiyo, F., & Kudanga, T. (2023) · Biomedical Materials · doi:10.1088/1748-605x/aceceb · Cited by 7
SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
Suvorov, A. N., Loginova, S. Y., Leontieva, G., Gupalova, T. V., Desheva, Y. A., Korzhevsky, D. E., Kramskaya, T. A., Bormotova, E., Koroleva, I. V., Kopteva, O. S., et al. (2023) · Vaccines · doi:10.3390/vaccines11111714 · Cited by 5
Antifouling Surface Coatings for the Next Generation of Nanomedicine: Toward in Vivo Immune Evasion
Forgham, H., Liu, L., Davis, T. P., & Qiao, R. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0316 · Cited by 5
Daoud, L., Hoang, S., Milin-Moguerou, A., Eyer, J., Breton, T., Montembault, V., Fontaine, L., Passirani, C., Saulnier, P., & Krupka, O. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c01738 · Cited by 4
Tuning the Functional Properties of Nanocarriers Using Tunable Nano‐Biointerfaces
Pancaro, A., Mailänder, V., Landfester, K., & Ethirajan, A. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202508121 · Cited by 5
Streiber, M., Schubert, U. S., & Traeger, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115023 · Cited by 7
Cheng, M., Yu, X., Qi, S., Yang, K., Lu, M., Cao, F., & Yu, G. (2024) · Angewandte Chemie · doi:10.1002/ange.202407398 · Cited by 4
Exploring the impact of lipid nanoparticles on protein stability and cellular proteostasis
Gao, Z., Jing, B., Wang, Y., Wan, W., Dong, X., & Liu, Y. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.08.146 · Cited by 4
Patel, J., Parikh, S., & Patel, S. (2021) · doi:10.53049/tjopam.2021.v001i01.001 · Cited by 4
PEG-Free Polyion Complex Nanocarriers for Brain-Derived Neurotrophic Factor
Fay, J. M., Lim, C., Finkelstein, A., Batrakova, E. V., & Kabanov, A. V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071391 · Cited by 4
Right Biceps Pseudo-Tumor from COVID-19 Vaccination
Abbas, A. M., Caicedo, M., & Damron, T. A. (2024) · Vaccines · doi:10.3390/vaccines12020160 · Cited by 4
Metadata
- Authors
- Moghimi, S. M.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Moghimi, S. Moein
- ORCID
- Moghimi, S. Moein
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 29
- Issue
- 3
- Pages
- 898-900
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC7862013
- OpenAlex
- W3126797562
- Cited by
- 150
- References
- 19
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 33 · 2023: 33 · 2022: 32 · 2021: 20
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- allergic reactions, anaphylaxis, COVID-19 vaccines, SARS-CoV-2, BNT162b2, Moderna vaccine, vaccine safety, emergency use authorization
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, BNT162 Vaccine, 2019-nCoV Vaccine mRNA-1273, Amino Alcohols, Anaphylaxis, Decanoates, Excipients, Humans, Liposomes, Polyethylene Glycols, Vaccines, Synthetic, Mass Vaccination, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
